School of Medicine
Showing 1-10 of 32 Results
Academic Program and Research Officer, Pediatrics - Infectious Diseases
Current Role at Stanford Program Manager, Global Child Health Program
Clinical Professor, Pediatrics - Adolescent Medicine
Current Research and Scholarly Interests Access to health care services for adolescents.
Mental Health Financing.
Postdoctoral Research fellow, Pediatrics Cancer Biology
Current Research and Scholarly Interests I am a postdoctoral fellow co-advised by Dr Julien Sage and Dr Marius Wernig at Stanford University where I am furthering my doctoral studies in mammalian epigenetics by investigating processes underlying cellular dedifferentiation. In particular, I am studying the role of the Retinoblastoma (RB) tumor suppressor, the primary gene of interest in the Sage laboratory, which has been shown to be a critical transcriptional regulator in part by controlling the epigenetic landscape at target genes. I am utilizing the process of induced pluripotency, an expertise of the Wernig laboratory, to drive dedifferentiation. I have shown that RB does indeed regulate dedifferentiation, in part by the silencing of critical pluripotency genes. Further investigation of the role of RB in dedifferentiation could reveal important insights into the mechanism by which Rb can prevent tumor formation, and consequently how a loss of Rb activity can make a cell cancer prone. In the future I will be investigating how the innate properties of cellular plasticity and variability define cell identity and can affect various states of disease, including cancer, or regeneration. To acheive these ends I employ a host of the latest genomic, systems biology, and single-cell techniques, along with classical molecular and cellular approaches to address these fundamental questions.
Clinical Instructor, Pediatrics - Infectious Diseases
Bio I am an Internist and Pediatrician trained in Pediatric Infectious Diseases. I provide clinical care on the Pediatric Infectious Diseases consult service and I am a medical officer with the Tuberculosis Control Branch at the California Department of Public Health. There I provide clinical consultation on MDR TB in addition to contributing to outbreak control and policy. My prior research, in the lab of Dr. Catherine Blish, explored anti-viral immunity and the systemic immune changes that occur during pregnancy. Throughout my career I have focused on improving care for underserved populations and have an interest in pediatric HIV and TB in resource-limited settings.
Mark A. Kay, M.D., Ph.D.
Dennis Farrey Family Professor in Pediatrics, and Professor of Genetics
Current Research and Scholarly Interests Mark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.
Professor of Pediatrics (Gastroenterology) at the Lucile Salter Packard Children's Hospital
Current Research and Scholarly Interests I am interested in pediatric nutritional support and have experience evaluating new enteral and parenteral products especially for the neonate (I studied a "new" I.V. fat product for Abbott; I participated in a multicenter trial of a formula with fish oil in it for neonates with Mead Johnson and a multicenter trial of a new human milk fortifier for Wyeth).